In most species, size homeostasis appears to be exerted in late G1 phase as cells commit to 34 division, called Start in yeast and the Restriction Point in metazoans. This size threshold couples 35 cell growth to division and thereby establishes long-term size homeostasis. Our former 36 investigations have shown that hundreds of genes markedly altered cell size under homeostatic 37 growth conditions in the opportunistic yeast Candida albicans, but surprisingly only few of these 38 overlapped with size control genes in the budding yeast Saccharomyces cerevisiae. Here, we 39 investigated one of the divergent potent size regulators in C. albicans, the Myb-like HTH 40 transcription factor Dot6. Our data demonstrated that Dot6 is a negative regulator of Start and 41 also acts as a transcriptional activator of ribosome biogenesis (Ribi) genes. Genetic epistasis 42 uncovered that Dot6 interacted with the master transcriptional regulator of the G1 machinery, 43 SBF complex, but not with the Ribi and cell size regulators Sch9, Sfp1 and p38/Hog1. Dot6 was 44 required for carbon-source modulation of cell size and it is regulated at the level of nuclear 45 localization by TOR pathway. Our findings support a model where Dot6 acts as a hub that 46
In a eukaryotic organism, cell size homeostasis is maintained through a balanced coordination 76 between cell growth and division. In the last half century, a major focus of cell biology has been 77 the study of cell division, but how eukaryotic cells couple growth to division to maintain a 78 homeostatic size remains poorly understood. In most eukaryotic organisms, reaching a critical 79 cell size appears to be crucial for commitment to cell division in late G1 phase, called Start in 80 yeast and the Restriction Point in metazoans (TURNER et al. 2012) . Start is dynamically regulated 81 by nutrient status, pheromone and stress, and facilitates adaptation to changing environmental 82 conditions in microorganisms to maximize their fitness (LENSKI AND 
Materials and Methods

136
Growth conditions and C. albicans Strains 137
The strains used in this study are listed in Table S1 . C. albicans strains were generated and 138 propagated using standard yeast genetics methods. For general propagation and maintenance 139 conditions, the strains were cultured at 30°C in yeast-peptone-dextrose (YPD) medium 140 supplemented with uridine (2% Bacto-peptone, 1% yeast extract, 2% dextrose, and 50 µg/ml 141 uridine) or in Synthetic Complete medium (SC; 0.67% yeast nitrogen base with ammonium 142 sulfate, 2% glucose, and 0.079% complete supplement mixture The critical cell size at Start was determined by plotting budding index as a function of size in 163 synchronous G1 phase fractions obtained using a JE-5.0 elutriation rotor with 40 ml chamber in a 164 J6-Mi centrifuge (Beckman, Fullerton, CA) as described previously (TYERS et al. 1993 ). C. 165
albicans G1 phase cells were released in fresh YPD medium and fractions were harvested at an 166 interval of 10 min to monitor bud index. For the dot6 mutant and the WT strains, additional size 167 fractions were collected to assess transcript levels of the RNR1, PCL2 and ACT1 using qPCR 168 (quantitative real time PCR) as cells progressed through G1 phase at progressively larger sizes. 169
Growth assays 170 C. albicans cells were resuspended in fresh SC at an OD 600 of 0. 
Expression analysis by qPCR 210
For qPCR experiments, cell cultures and RNA extractions were performed as described for the 211 microarray experiment. cDNA was synthesized from 1µg of total RNA using the SuperScipt III 212
Reverse Transcription kit (ThermoFisher). The mixture was incubated at 25°C for 10 min, 37°C 213
for 120 min and 85°C for 5 min. 2U/µl of RNAse H (NEB) was added to remove RNA and 214 samples were incubated at 37°C for 20 min. qPCR was performed using an iQ5 96-well PCR 215 system (BioRad) for 40 amplification cycles with QuantiTect SYBR Green PCR master mix 216 (Qiagen). The reactions were incubated at 50°C for 2 min, 95°C for 2min and cycled 40 times at 217 95°C, 15 s; 56°C, 30 s; 72°C, 1 min. Fold-enrichment of each tested transcripts was estimated 218
using the comparative Ct method as described by Guillemette et al. (GUILLEMETTE et al. 219 2004). To evaluate the gene expression level, the results were normalized using Ct values 220 obtained from Actin (ACT1, C1_13700W_A). Primer sequences used for this analysis are 221 summarized in Supplemental Table S2 .
223
Data Availability 224
Strains and plasmids are available upon request. Supplemental files contain three figures (Figure 225 S1-S3) and four tables ( 
Results
228
Dot6 is a negative regulator of START in C. albicans 229 We have previously shown that the transcription factor Dot6 was required for cell size control in 230 C. albicans (SELLAM et al. 2016). A dot6 mutant had a median size that was 21% (41fL) smaller 231 than its congenic parental (52fL) or the complemented strains (51fL) ( Figure 1A) . Inactivation 232 of DOT6 resulted in a delayed exit from the lag phase (1.5h delay as compared to the WT) 233 ( Figure 1B) . However, dot6 had a doubling time comparable to the WT and the complemented 234 strains during the log phase suggesting that the size reduction of dot6 is not a growth rate-235 associated phenotype (Figure 1B) . To ascertain that this effect was mediated at Start, we 236 evaluated two hallmarks of Start, namely bud emergence and the onset of SBF-dependent 237 transcription as a function of cell size in synchronous G1 phase cells obtained by elutriation. As 238 assessed by median size of cultures for which 90% of cells had a visible bud, the dot6 mutant 239
passed Start after growth to 26fL, whereas a parental WT control culture became 90% budded at 240 a much larger size of 61fL ( Figure 1C) . Importantly, in the same experiment, the onset G1/S 241 transcription was accelerated in the dot6 strain as judged by the peak in expression of the two 242 representative G1-transcripts, the ribonucleotide reductase large subunit, RNR1 and the cyclin 243 PCL2 (Figure 1D-E hog1 or sch9 resulted in cells with smaller size as compared to their congenic strains suggesting 254 that Dot6, Sfp1, Sch9 and the p38 kinase Hog1 act in different Start pathways (Figure 2A-C) . 255 Furthermore, inactivation of DOT6 in the swi4 mutant resulted in a large size comparable to that 256 of swi4 mutant indicating that Dot6 acts via SBF complex to control Start (Figure 2D) . SWI4 257 deletion is also epistatic to DOT6 regarding the growth rate in liquid YPD medium confirming 258 that both Dot6 and Swi4 act in a common pathway (Figure 2E) . Given the absence of epistatic 259
interaction between Dot6 and the known conserved Ribi and size regulators Sch9, Sfp1 and 260
Hog1, our data uncovered a novel uncharacterized pathway that control the critical cell size 261 threshold in C. albicans (Figure 2F) functions mainly associated with protein translation, including ribosome biogenesis and 273 structural constituents of the ribosome (Figure 3A) . This suggest that in contrast to the role of its 274 orthologue in S. cerevisiae, Dot6 in C. albicans is an activator of RiBi. Analysis of promoter 275 region of transcript downregulated in dot6 (transcript with 1.5-fold reduction using 5% FDR-276 Table S3 ) showed the occurrence of the PAC motif bound by Dot6 in all promoters of genes 277 related to RiBi (Figure 3B) . Furthermore, transcripts downregulated in dot6 exhibited correlation 278
with the set of genes repressed by the TOR complex inhibitor, rapamycin. This suggest that the 279 evolutionary conserved RiBi transcription control by TOR is mediated fully or partially through 280
Dot6. In support of the role of Dot6 in transcriptional control of Ribi genes and thus translation, 281 dot6 mutant exhibited an increased sensitivity to the protein translation inhibitor cycloheximide 282 as compared to the WT and the revertant strains (Figure 3C) . In C. albicans, while sfp1 and sch9 mutants have the expected small size phenotype (SELLAM et  298 al. 2016), they still retain the ability to respond to carbon source shifts, unlike the S. cerevisiae 299 counterparts (Figure S1 ). This suggest that the Sfp1-Sch9 regulatory circuit had rewired and is 300 unlikely to rely on the nutrient status of the cell to Start control in C. albicans. 301
To assess whether the nutrient-sensitive TOR pathway communicates the nutrient status to Dot6, 302
we first tested whether altering TOR activity by rapamycin could alter the subcellular 303 localization of the Dot6-GFP fusion. In the absence of rapamycin, Dot6-GFP was localized 304 exclusively in the nucleus in agreement with its role as a transcriptional activator under nutrient 305 rich environment (Figure 4A-C) . A weak GFP signal was also observed in the nucleolus and the 306 vacuole. When cells were treated with rapamycin, Dot6-GFP was rapidly relocalized to the 307 vacuole and only a small fraction remain in the nucleus (Figure 4D-F) . The vacuolar localization 308 of the Dot6-GFP was confirmed by its co localization with the CellTracker Blue-stained 309 vacuoles (Figure S2) . These data suggest that TOR pathway regulates the transcriptional 310 function of Dot6. 311 312
To assess whether the control of Dot6 activity by TOR impacts the cell size of C. albicans, we 313 examined genetic interactions between TOR1 and DOT6 by size epistasis. As TOR1 is an 314 essential gene in C. albicans, we first tried to delete one allele in dot6 homozygous mutant. 315
However, all attempts to generate such mutant were unsuccessful suggesting a haplo-essentiality 316 of TOR1 in dot6 mutant background. Subsequently, we analysed genetic interaction of TOR1 and 317 DOT6 using complex haploinsufficiency (CHI) concept by deleting one allele of each gene and 318 measured size distribution of the obtained mutant. While both DOT6/dot6 and TOR1/Tor1 319 mutants had no disenable size defect, the TOR1/tor1 DOT6/dot6 strain exhibited cell size 320 distribution similar to that of dot6/dot6, suggesting that DOT6 is epistatic to TOR1 (Figure 4G) . 321 Similarly, DOT6 was also epistatic to TOR1 with respect to their sensitivity toward rapamycin 322 (Figure 4H) . These data demonstrate that TOR pathway control cell size through Dot6. 323 324
Dot6 is required for carbon-source modulation of cell size 325
The effect of different carbon sources was assessed on the size distribution of the dot6 mutant 326 and the WT. While the cell size of WT and the revertant strains was reduced by 12 % (47.6  0.5 327 fL) when grown under the poor carbon source, glycerol, as compared to glucose (54.2  0.5 fL), 328
dot6 size remain unchanged regardless the carbon source (Figure 5A-B) . Similar finding was 329
obtained when comparing cells growing on the non-fermentable carbon source, ethanol (data not 330 shown). These results demonstrate that the transcription factor Dot6 is required for nutrient 331 modulation of cell size. Furthermore, strain lacking DOT6 was rate-limiting when grown in 332 medium with glycerol as a sole source of carbon as compared to glucose (Figure 5C ). 333 334
To check whether Dot6 localization is modulated by carbon sources, the subcellular localization 335 of the Dot6-GFP fusion was tested in cells that grew in poor (glycerol) or in the absence of 336 carbon sources. Neither the absence or the quality of carbon sources altered the nuclear 337 localization of Dot6 (data not shown). This suggest that Dot6 govern the carbon-source 338 modulation of cell size through a mechanism that is independent from its cellular relocalization 339 340
The CTG-clade specific acidic domain of Dot6 is not required for size control 341
Our analysis unexpectedly reveals that Dot6 switched between activator and repressor 342 transcriptional regulator of Ribi between C. albicans and S. cerevisiae, respectively. Sequence 343 examination of C. albicans Dot6 protein revealed a C-terminal aspartate-rich domain that is 344 similar to acidic activation domains of transcriptional activators. This Dot6 D-rich domain was 345
found specifically in C. albicans and other related species of the CTG clade, and it was absent in 346
Dot6 orthologs in S. cerevisiae and other ascomycetes (Figure 6A) . To check whether the 347 presence of this acidic domain corroborates with its function as transcriptional activator in C. 348 albicans, we deleted this D-rich domain using CRISPR-Cas9 mutagenesis tool. Size distribution 349 of the truncated DOT6-[1555-1803] strain was indistinguishable from that of the WT parental 350 strain (Figure 6B) . The ability of DOT6-[1555-1803] to activate two Ribi transcripts (DBP7 351 and KRE33) was preserved which suggest that this domain is dispensable for the size control and 352 gene expression activation functions of Dot6 (Figure 6C) . Dot6 for the fitness of C. albicans inside its host was not tested yet, however, inactivation of 368 DOT6 led to the alteration of different virulence traits such as the sensitivity toward antifungals 369 (VANDEPUTTE et al. 2012) . Moreover, while dot6 mutant was able to form invasive filaments, the 370 size of hyphae cells was significantly reduced which might impact the invasiveness of host 371 tissues and organs (Figure S3) . This reinforce the fact that control of cell size homeostasis is an 372 important attribute for this C. albicans to persist inside its host. 373 374 We found that Dot6 is a major regulator of cell size in C. albicans as compared to S. cerevisiae 375 emphasizing an evolutionary drift regarding the contribution of this transcription factor in size 376 modulation. The potency of the C. albicans Dot6 in size control could be attributed to different 377 facts. First, and in contrast to its role in S. cerevisiae, Dot6 is an activator of Ribi genes. This 378 might explain the small size of dot6 in C. albicans given the fact that inactivation of 379 transcriptional activators of Ribi genes such as Sfp1 and Sch9 in either S. cerevisiae or C. critical SBF complex, that control the the G1/S transition, and also with the TOR growth and 384
Ribi machineries, which might explain the influential role of Dot6 in size control. 385 386
Our findings support a model where Dot6 acts as a hub that might integrate directly growth cues 387 via the TOR pathway to control the commitment to mitotic division at G1. This regulatory 388
behavior is similar to the p38/HOG1 pathway that controls the Ribi regulon through the master 389 transcriptional regulator, Sfp1, and acts upstream the SBF transcription factor complex to control 390 division (SELLAM et al. 2016) . Meanwhile, our genetic interaction analysis showed that the dot6 391 hog1 double mutant had an additive small size phenotype suggesting that both Dot6 and Hog1 392 act in parallel. This finding emphasizes that, in C. albicans, multiple signals are integrated at the 393 level of G1 machinery to optimize adaptation to different conditions. Contrary to the p38/HOG 394 pathway, Dot6 were required for both growth and size adjustment in response to glycerol 395
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